Literature DB >> 26719269

Plasmacytoid Dendritic Cells Require Direct Infection To Sustain the Pulmonary Influenza A Virus-Specific CD8 T Cell Response.

Emily A Hemann1, Louisa E Sjaastad2, Ryan A Langlois3, Kevin L Legge4.   

Abstract

UNLABELLED: Following influenza A virus (IAV) infection, development of a robust IAV-specific CD8 T cell response is required for clearance of primary infection and enhances memory protection. Following IAV infection, plasmacytoid dendritic cells (pDC) or CD8α(+) DC regulate pulmonary effector CD8 T cell responses within the lung. Without this DC-T cell interaction, insufficient effector CD8 T cells are maintained in the lungs, leading to enhanced morbidity and mortality. Previous studies have demonstrated that pDC are capable of classical presentation or cross-presentation of IAV antigens and could potentially regulate IAV-specific CD8 T cell responses through either mechanism. Our results demonstrate that pDC from the lungs of donor mice infected with an IAV that is not able to replicate in hematopoietic cells (142t-IAV), unlike donor pDC isolated from the lungs of control infected mice, are not able to rescue the host IAV-specific CD8 T cell response from apoptosis. This indicates that pDC must utilize the direct presentation pathway for this rescue. This inability of pDC from 142t-IAV donors to rescue the IAV-specific CD8 T cell response is not due to differences in the overall ability of 142t-IAV to replicate within the lungs or generate defective viral genomes or to differences in levels of costimulatory molecules required for this interaction. We further demonstrate that bypassing the antigen presentation pathway by coating the 142t-IAV pDC with IAV peptide epitopes restores their ability to rescue the IAV-specific CD8 T cell response. IMPORTANCE: IAV continues to be a global health burden, infecting 5 to 20% of the global population annually. Continued investigation into the mechanisms that mediate protective immune responses against IAV is important to improving current vaccination and antiviral strategies antagonistic toward IAV. Our findings presented herein demonstrate a key requirement for pDC promotion of effector CD8 T cell survival: that rather than utilizing cross-presentation, pDC must be infected and utilize the endogenous pathway for presentation of antigens to CD8 T cells during in vivo IAV infections. This suggests that targeting presentation via the endogenous pathway in pDC could be important for the development of unique antiviral cellular therapies.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26719269      PMCID: PMC4810669          DOI: 10.1128/JVI.02546-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.

Authors:  J L Pooley; W R Heath; K Shortman
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

2.  Cell-mediated immune responses in humans after induced infection with influenza A virus.

Authors:  R Dolin; D D Richman; B R Murphy; A S Fauci
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

3.  Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

Authors:  Stefan Nierkens; Jurjen Tel; Edith Janssen; Gosse J Adema
Journal:  Trends Immunol       Date:  2013-03-27       Impact factor: 16.687

Review 4.  Development of antigen cross-presentation capacity in dendritic cells.

Authors:  Christiane Dresch; Yann Leverrier; Jacqueline Marvel; Ken Shortman
Journal:  Trends Immunol       Date:  2012-06-05       Impact factor: 16.687

5.  Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.

Authors:  Sandra S Diebold; Tsuneyasu Kaisho; Hiroaki Hemmi; Shizuo Akira; Caetano Reis e Sousa
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

6.  Mononuclear phagocyte miRNome analysis identifies miR-142 as critical regulator of murine dendritic cell homeostasis.

Authors:  Alexander Mildner; Elik Chapnik; Ohad Manor; Simon Yona; Ki-Wook Kim; Tegest Aychek; Diana Varol; Gilad Beck; Zohar Barnett Itzhaki; Ester Feldmesser; Ido Amit; Eran Hornstein; Steffen Jung
Journal:  Blood       Date:  2012-12-04       Impact factor: 22.113

7.  Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity.

Authors:  Jean-François Fonteneau; Michel Gilliet; Marie Larsson; Ida Dasilva; Christian Münz; Yong-Jun Liu; Nina Bhardwaj
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

8.  CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

Authors:  J M den Haan; S M Lehar; M J Bevan
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

9.  Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity.

Authors:  Karla Tapia; Won-Keun Kim; Yan Sun; Xiomara Mercado-López; Emily Dunay; Megan Wise; Michael Adu; Carolina B López
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

10.  Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles.

Authors:  Timo Frensing; Frank Stefan Heldt; Antje Pflugmacher; Ilona Behrendt; Ingo Jordan; Dietrich Flockerzi; Yvonne Genzel; Udo Reichl
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more
  8 in total

1.  Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.

Authors:  Chunmei Fu; Peng Peng; Jakob Loschko; Li Feng; Phuong Pham; Weiguo Cui; Kelvin P Lee; Anne B Krug; Aimin Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-02       Impact factor: 11.205

Review 2.  Tissue-resident innate immunity in the lung.

Authors:  Amanda Ardain; Mohlopheni J Marakalala; Alasdair Leslie
Journal:  Immunology       Date:  2019-11-21       Impact factor: 7.397

Review 3.  Mucosal immune responses to infection and vaccination in the respiratory tract.

Authors:  Robert C Mettelman; E Kaitlynn Allen; Paul G Thomas
Journal:  Immunity       Date:  2022-05-10       Impact factor: 43.474

Review 4.  Antigen Presentation in the Lung.

Authors:  Takumi Kawasaki; Moe Ikegawa; Taro Kawai
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

Review 5.  Pathogenesis of Respiratory Viral and Fungal Coinfections.

Authors:  Fabián Salazar; Elaine Bignell; Gordon D Brown; Peter C Cook; Adilia Warris
Journal:  Clin Microbiol Rev       Date:  2021-11-17       Impact factor: 26.132

Review 6.  Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections.

Authors:  Cynthia Calzas; Christophe Chevalier
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

Review 7.  Host Protective Immune Responses against Influenza A Virus Infection.

Authors:  Hi Eun Jung; Heung Kyu Lee
Journal:  Viruses       Date:  2020-05-03       Impact factor: 5.048

Review 8.  Plasmacytoid Dendritic Cells and Cancer Immunotherapy.

Authors:  Chunmei Fu; Li Zhou; Qing-Sheng Mi; Aimin Jiang
Journal:  Cells       Date:  2022-01-11       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.